Denali Therapeutics Inc

DNLINASDAQ · USD
18.74USD0.00 (-0.80%)
137

Denali Therapeutics Inc (DNLI) Option Chain

Read more

Tracking the DNLI option chain helps you see every strike and expiry on Denali Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of DNLI options activity at a glance. Use our scanner to monitor the DNLI option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For DNLI stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where DNLI options are being actively traded, and where they are not.

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for the treatment of hunter syndrome; DNL343, which is in phase 1 clinical trial the treatment of amyotrophic lateral sclerosis (ALS); AR443820/DNL788 completed a phase I clinical trial for the treatment of ALS, multiple sclerosis (MS), and Alzheimer's disease; and SAR443122/DNL758, which is in phase II clinical trial for the treatment of cutaneous lupus erythematosus.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.261000.016.244.208.3012.50-33.30—3.400.003.400099.74
6.62000.043.741.755.8015.00-19.96—3.500.003.500193.38
33.8214002.861.24—4.1017.50-6.62—3.500.003.50016266.18
70.0016303.500.00—3.5020.00+6.72—4.101.262.84020830.00
91.2342700.650.00—0.6522.50+20.061.805.803.760.044138.77

As of Nov 13, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank91.27% High
  • Market cap (M$)3,004
  • 52 weeks high-31.36%
  • 52 weeks low22.16%
  • Analyst recommendationStrong Buy
    1.14
  • Target price$35.82
    91.14% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-03
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.74
  • EPS growth next 5 years16.85%

As of Nov 13, 2026